The diagnosis of DIIHA for the patient in this case was further supported by the patient's clinical presentation and laboratory findings, including decreased haptoglobin, elevated LDH, increased reticulocyte count, and indirect hyperbilirubinemia, in conjunction with the temporal relationship to dapagliflozin initiation. The gene discussed is HP; the disease is Hyperbilirubinemia.